fig2

Evidence and mechanisms linking obesity to cardiovascular disease

Figure 2. Mechanisms of adipocytokine- and pro-inflammatory cytokine-mediated atherosclerosis. Adipocytokines and pro-inflammatory cytokines promote atherosclerosis by enhancing macrophage lipid accumulation and impairing endothelial function. In macrophages, TNF-α binds to TNFR1 and activates the TNFR1 signaling complex, including TRADD, RIPK1, TRAFs, and cIAPs, thereby inducing IKKβ activation and subsequent NF-κB signaling. IL-6 signaling through the IL-6Rα/GP130 complex activates the JAK1/STAT3 pathway and further augments NF-κB activity. Activated NF-κB upregulates CD36 and SR-A expression, thereby increasing ox-LDL uptake, while simultaneously enhancing ACAT1 expression to promote the esterification of free cholesterol into cholesteryl esters. In parallel, suppression of LXRα-dependent ABCA1 and ABCG1 expression impairs cholesterol efflux. Together, these alterations promote intracellular cholesterol accumulation and foam-cell formation. In endothelial cells, TNF-α/TNFR1 and IL-6/IL-6Rα/GP130 signaling activate NF-κB, resulting in eNOS downregulation and reduced nitric oxide bioavailability, increased VCAM-1 and ICAM-1 expression with enhanced monocyte adhesion and transmigration, and reduced expression of endothelial junctional proteins, including ZO-1, claudin-5, and JAM-A. Collectively, these changes impair endothelium-dependent vasodilation, increase inflammatory cell recruitment and endothelial permeability, and ultimately promote endothelial dysfunction and atherosclerotic plaque development. TNF-α: Tumor necrosis factor-α; TNFR1: tumor necrosis factor receptor 1; TRADD: TNFR1-associated death domain protein; RIPK1: receptor-interacting serine/threonine-protein kinase 1; TRAF: TNF receptor-associated factor; cIAP: cellular inhibitor of apoptosis protein; IKKβ: inhibitor of nuclear factor κB kinase β; NF-κB: nuclear factor κB; IL-6: interleukin-6; IL-6Rα: interleukin-6 receptor α; GP130: glycoprotein 130; JAK1: Janus kinase 1; STAT3: signal transducer and activator of transcription 3; CD36: cluster of differentiation 36; SR-A: scavenger receptor A; ox-LDL: oxidized low-density lipoprotein; ACAT1: acyl-CoA:cholesterol acyltransferase 1; LXRα: liver X receptor α; ABCA1/ABCG1: ATP-binding cassette transporters A1/G1; eNOS: endothelial nitric oxide synthase; NO: nitric oxide; VCAM-1: vascular cell adhesion molecule-1; ICAM-1: intercellular adhesion molecule-1; ZO-1: zonula occludens-1; JAM-A: junctional adhesion molecule A.